Status: current, Primitive. Date: 31-Jan 2017. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3330101014 | Iron-refractory iron deficiency anemia (disorder) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3330102019 | Iron-refractory iron deficiency anemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
3330103012 | Iron-refractory iron deficiency anaemia | en | Synonym | Active | Case insensitive | SNOMED CT core |
3330104018 | IRIDA syndrome | en | Synonym | Active | Case sensitive | SNOMED CT core |
3330105017 | IRIDA (iron-refractory iron deficiency anaemia) syndrome | en | Synonym | Active | Case sensitive | SNOMED CT core |
3330106016 | IRIDA (iron-refractory iron deficiency anemia) syndrome | en | Synonym | Active | Case sensitive | SNOMED CT core |
3330107013 | A rare autosomal recessive iron metabolism disorder characterized by iron deficiency anemia (hypochromic, microcytic) that is often unresponsive to oral iron intake and partially responsive to parenteral iron treatment. 50 patients from 32 families of different ethnic origin have been described to date; however, it is likely that this condition is underdiagnosed. Most IRIDA patients have no major clinical signs, except for pallor, and have normal growth and development. IRIDA syndrome is due to mutations the TMPRSS6 gene encoding Matriptase 2, a transmembrane serine protease that plays an essential role in down-regulating hepcidin, the key regulator of iron homeostasis. Transmission is autosomal recessive. | en | Definition | Active | Case sensitive | SNOMED CT core |
3330108015 | A rare autosomal recessive iron metabolism disorder characterised by iron deficiency anaemia (hypochromic, microcytic) that is often unresponsive to oral iron intake and partially responsive to parenteral iron treatment. 50 patients from 32 families of different ethnic origin have been described to date; however, it is likely that this condition is underdiagnosed. Most IRIDA patients have no major clinical signs, except for pallor, and have normal growth and development. IRIDA syndrome is due to mutations the TMPRSS6 gene encoding Matriptase 2, a transmembrane serine protease that plays an essential role in down-regulating hepcidin, the key regulator of iron homeostasis. Transmission is autosomal recessive. | en | Definition | Active | Case sensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Iron-refractory iron deficiency anaemia | Due to | Iron deficiency | true | Inferred relationship | Some | 1 | |
Iron-refractory iron deficiency anaemia | Is a | Autosomal recessive hereditary disorder | true | Inferred relationship | Some | ||
Iron-refractory iron deficiency anaemia | Is a | Iron deficiency anaemia | true | Inferred relationship | Some | ||
Iron-refractory iron deficiency anaemia | Has interpretation | Below reference range | true | Inferred relationship | Some | 3 | |
Iron-refractory iron deficiency anaemia | Interprets | Measurement of total haemoglobin concentration | true | Inferred relationship | Some | 3 | |
Iron-refractory iron deficiency anaemia | Has interpretation | Below reference range | true | Inferred relationship | Some | 4 | |
Iron-refractory iron deficiency anaemia | Interprets | Red blood cell count | true | Inferred relationship | Some | 4 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian emergency department reference set
Clinical finding foundation reference set
Problem/Diagnosis reference set